Disseminated herpes simplex virus type-1 infection in long-term usage of everolimus

Journal of Dermatology

Volumn 40, Issue 1, 2013, Pages 84-85

  Koga, Monji ^a   Nakayama, Ichiro ^b   Sakai, Teppei ^a   Koga, Kaori ^b   Imafuku, Shinichi ^a   Nakayama, Juichiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; EVEROLIMUS; PREDNISOLONE;

ADULT; BACTERIUM CULTURE; CASE REPORT; CELL INCLUSION; CELL NUCLEUS INCLUSION BODY; CORTICOSTEROID THERAPY; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG WITHDRAWAL; EDEMA; EPIDERMIS CELL; EROSION; FATIGUE; FEVER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI VARICELLIFORM ERUPTION; KERATINOCYTE; KIDNEY CARCINOMA; LETTER; LONG TERM CARE; MALE; SKIN BIOPSY; SKIN PRURITUS; STEVENS JOHNSON SYNDROME; TREATMENT DURATION; VIRAL SKIN DISEASE;

EID: 84872498370     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2012.01674.x     Document Type: Letter

References (3)

1. Sánchez-Fructuoso AI, Ruiz JC, Pérez-Flores I, et al,. Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus. Transplant Proc 2010; 42: 3050-2.
2. Campistol JM, de Fijter JW, Flechner SM, et al,. mTOR inhibitor-associated dermatologic and mucosal problems. Clin Transplant 2010; 24: 149-56.
3. Charpentier B, Groth CG, Bäckman L, et al,., Sirolimus European Renal Transplant Study Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study. Transplant Proc 2003; 35: 58-61.